Trial Profile
Phase III trial of doxorubicin administered via isolated hepatic infusion (Delcath system) compared with controls in patients with liver metastases from malignant melanoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Aug 2012
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Cancer metastases; Malignant melanoma
- Focus Registrational; Therapeutic Use
- 23 Aug 2006 New trial record.